https://www.ncbi.nlm.nih.gov/pubmed/?term=alzahrani+sh
· Coagulation and fibrinolysis in diabetes. Alzahrani SH, Ajjan RA. Diab Vasc Dis Res. 2010 Oct;7(4):260-73 Sep, 2010
· A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.Hess K, Alzahrani SH, Mathai M, Schroeder V, Carter AM, Howell G, Koko T, Strachan MW, Price JF, Smith KA, Grant PJ, Ajjan RA. Diabetologia. Sep. 2011
· Thyroid Dysfunction and Fibrin Network Structure: A Mechanism for Increased Thrombotic Risk in Hyperthyroid Individuals., JMW Hooper, SM Orme, B van Zaane, K Hess, Alzahrani SH, KF Standeven, SHS Pearce, PJ Grant and RA Ajjan, J Clin Endocrinol Metab. May 2012; 2012;97(5):1463-73
· Fibrin clot structure and fibrinolysis in type 2 diabetes: The effects of vascular disease, cardiometabolic risk factors and therapeutic agents. Alzahrani SH, Hess K, Strachan K, Price JF, Baxter PD, Cubbon R, Phoenix F, Heller S, Grant P, Ajjan RA J Clin Endocrinol Metab. Sep 2012 20. [Epub ahead of print]
· Fibrin clot structure and fibrinolysis in hypothyroid individuals: the effects of normalising thyroid hormone levels. Stuijver DJ, Hooper JM, Orme SM, Van Zaane B, Squizzato A, Piantanida E, Hess K, Alzahrani S, Ajjan RA. J Thromb Haemost. 10(8):1708-10
· Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3. Hess K, Alzahrani SH, Price JF, Strachan MW, Oxley N, King R, Gamlen T, Schroeder V, Baxter PD, Ajjan RA. Diabetologia. 2014 Aug;57(8):1737-41.
· Characterization of thyroid function and antithyroid antibody tests among Saudis.Jammah AA, Alshehri AS, Alrakhis AA, Alhedaithy AS, Almadhi AM, Alkwai HM, Alhamad MM, Alzahrani SH. Saudi Med J. 2015 Jun;36(6):692-7. doi: 10.15537/smj.2015.6.11591.
· Factors associated with diabetes mellitus prediction among pregnant Arab subjects with gestational diabetes. Aljohani N, Al Serehi A, Ahmed AM, Buhary BA, Alzahrani S, At-Taras E, Almujally N, Alsharqi M, Alqahtani M, Almalki M. Int J Clin Exp Pathol. 2015 Jul 1;8(7):8512-5. eCollection 2015.
· Managing Prolactinomas during Pregnancy. Almalki MH, Alzahrani S, Alshahrani F, Alsherbeni S, Almoharib O, Aljohani N, Almagamsi A. Front Endocrinol (Lausanne). 2015 May 26;6:85. Review.
· Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases. Almalki MH, Buhary B, Alzahrani S, Alshahrani F, Alsherbeni S, Alhowsawi G, Aljohani N.Pituitary. 2015 Jun;18(3):405-9. doi: 10.1007/s11102-014-0588-3.
· BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes. Greenhalgh KA, Strachan MW, Alzahrani S, Baxter PD, Standeven KF, Storey RF, Ariens RA, Grant PJ, Price JF, Ajjan RA. Thromb Haemost. 2017 Jan 26;117(2):295-302.
· The Saudi clinical practice guideline for the management of overweight and obesity in adults. Alfadda AA, Al-Dhwayan MM, Alharbi AA, Al Khudhair BK, Al Nozha OM, Al-Qahtani NM, Alzahrani SH, Bardisi WM, Sallam RM, Riva JJ, Brożek JL, Schünemann HJ, Moore A. Saudi Med J. 2016 Oct;37(10):1151-62.
Glycemic control and pregnancy outcomes in patients with diabetes in pregnancy: A retrospective study. Buhary BM, Almohareb O, Aljohani N, Alzahrani SH, Elkaissi S, Sherbeeni S, Almaghamsi A, Almalki M. Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):481-90.